Gastroenterology 132 , 21312157, doi:10.1053/j.gastro.2007.03.054 (2007)
The concept makes complete sense now
In June 2025, the World Health Organization warned that semaglutide medications such as Ozempic may rarely cause NAION and advised patients to seek immediate medical care after rapid eyesight changes
Only tirzepatide is FDA-approved for sleep apnea approved in 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity, the first medication ever FDA-approved for OSA
And I'm a big fan of that because as a clinician you need some guide, some efficient and effective way to treat the patient in front of you
Wang X, Li Q, Liu Y, Jiang H, Chen W (2021) Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: a systematic review and meta-analysis of randomized controlled trials